Metamphetamin induced psychotic disorder. Other stimulant abuse with stimulant-induced psychotic disorder
Conditions
Interventions
Intervention 1: intervention group 1:taking Risperidone oral tablet, 2-8mg over 24 hours variable dosage decided by clinical care giver, daily, for at least a month and abidi pharma brand. Interventio
Sponsors
University of social welfare and rehabilitation sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Men and women with written informed consent to enter the trial At least one Positive and Negative Syndrome Scale score equal or greater than 4 Methamphetamine use in less than 4 weeks leading to admition No other substance dependencies except for Tobacco diagnosis of Metamphetamin induced psychotic disorder according to Diagnostic and Statistical Manual of Mental Disorders, 5th Edition
Exclusion criteria
Exclusion criteria: Sever nonpsychiatric condition in which Risperidone or Aripiprazole are contraindicated Aripiprazole or Risperidone Allergies Active suicidal or homicidal thoughts Comorbid mood or anxiety disorders Pregnant or nursing women or high suspicion of pregnancy Psychiatric medication use in last 4 weeks other than Benzodiazepines
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of Positive and Negative Syndrome Scale. Timepoint: Days: 0, 7, 28 after medication. Method of measurement: Positive and Negative Syndrome Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSepehr Mazloomi Koohbanani
University of social welfare and rehabilitation sciences
Outcome results
None listed